Chief Executive Officer (CEO) – Biotech & Immunotherapy
New
O
Orion PlacementBiotechnology, immunotherapy
Remote – Nationwide (U.S.)Full-TimeExecutive
Salary250,000 - 400,000 USD per year
Apply NowOpens the employer's application page
Job Details
- Experience
- 8+ years of progressive leadership experience within biotechnology or biopharmaceutical companies.
- Required Skills
- Business DevelopmentNegotiation
Requirements
- Bring 8+ years of progressive leadership experience within biotechnology or biopharmaceutical companies.
- Demonstrate success raising significant capital and closing business development or outlicensing transactions.
- Have strong knowledge of drug development, clinical-stage biotechnology, and FDA regulatory requirements.
- Bring experience with immunotherapies, vaccines, biologics, or related therapeutic development.
- Demonstrate ability to develop corporate strategies, establish pharmaceutical partnerships, and lead growth-stage organizations.
- Have investor relations, negotiation, communication, and executive leadership skills.
- Experience with venture capital, government grants, M&A, or IPO preparation is highly desirable.
- A PhD, MD, or MBA is preferred.
Responsibilities
- Lead overall corporate strategy, operations, financing, and long-term business growth.
- Drive fundraising, including venture capital financing, institutional investments, and government funding opportunities.
- Build and execute pharmaceutical business development, strategic partnering, and product outlicensing strategies.
- Guide drug development programs through FDA regulatory milestones, clinical trials, and commercialization planning.
- Establish relationships with investors, pharmaceutical partners, government agencies, and scientific collaborators.
- Build, mentor, and lead executive, scientific, and operational teams.
- Partner with the Board of Directors to establish company priorities, manage resources, and maximize enterprise value.
View Full Description & ApplyYou'll be redirected to the employer's site
